These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2278733)

  • 1. X-ray crystal structure of the bovine alpha-chymotrypsin/eglin c complex at 2.6 A resolution.
    Bolognesi M; Pugliese L; Gatti G; Frigerio F; Coda A; Antolini L; Schnebli HP; Menegatti E; Amiconi G; Ascenzi P
    J Mol Recognit; 1990 Aug; 3(4):163-8. PubMed ID: 2278733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
    Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal and molecular structure of the bovine alpha-chymotrypsin-eglin c complex at 2.0 A resolution.
    Frigerio F; Coda A; Pugliese L; Lionetti C; Menegatti E; Amiconi G; Schnebli HP; Ascenzi P; Bolognesi M
    J Mol Biol; 1992 May; 225(1):107-23. PubMed ID: 1583684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the bovine alpha-chymotrypsin:Kunitz inhibitor complex. An example of multiple protein:protein recognition sites.
    Capasso C; Rizzi M; Menegatti E; Ascenzi P; Bolognesi M
    J Mol Recognit; 1997; 10(1):26-35. PubMed ID: 9179777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo.
    McPhalen CA; James MN
    Biochemistry; 1988 Aug; 27(17):6582-98. PubMed ID: 3064813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
    Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
    Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to serine (pro)enzymes: a comparative thermodynamic study.
    Ascenzi P; Aducci P; Amiconi G; Ballio A; Guaragna A; Menegatti E; Schnebli HP; Bolognesi M
    J Mol Recognit; 1991; 4(4):113-9. PubMed ID: 1799460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S; Stouch T; Novotny J
    J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of eglin-c binding to thermitase: three-dimensional structure comparison of native thermitase and thermitase eglin-c complexes.
    Gros P; Teplyakov AV; Hol WG
    Proteins; 1992 Jan; 12(1):63-74. PubMed ID: 1553381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function relationship of serine protease-protein inhibitor interaction.
    Otlewski J; Jaskólski M; Buczek O; Cierpicki T; Czapińska H; Krowarsch D; Smalas AO; Stachowiak D; Szpineta A; Dadlez M
    Acta Biochim Pol; 2001; 48(2):419-28. PubMed ID: 11732612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary crystallographic data on the complex of bovine alpha-chymotrypsin with the recombinant proteinase inhibitor eglin c from Hirudo medicinalis.
    Pugliese L; Gatti G; Bolognesi M; Coda A; Menegatti E; Schnebli HP; Ascenzi P; Amiconi G
    J Mol Biol; 1989 Aug; 208(3):511-3. PubMed ID: 2795659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases.
    Qasim MA; Ganz PJ; Saunders CW; Bateman KS; James MN; Laskowski M
    Biochemistry; 1997 Feb; 36(7):1598-607. PubMed ID: 9048543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray crystal structure of the serine proteinase inhibitor eglin c at 1.95 A resolution.
    Hipler K; Priestle JP; Rahuel J; Grütter MG
    FEBS Lett; 1992 Sep; 309(2):139-45. PubMed ID: 1505678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution structures of three new trypsin-squash-inhibitor complexes: a detailed comparison with other trypsins and their complexes.
    Helland R; Berglund GI; Otlewski J; Apostoluk W; Andersen OA; Willassen NP; Smalås AO
    Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):139-48. PubMed ID: 10089404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
    Azim MK; Grossmann JG; Zaidi ZH
    J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the proteinase inhibitor eglin c with hydrolysed reactive centre at 2.0 A resolution.
    Betzel C; Dauter Z; Genov N; Lamzin V; Navaza J; Schnebli HP; Visanji M; Wilson KS
    FEBS Lett; 1993 Feb; 317(3):185-8. PubMed ID: 8425603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry.
    Bode W; Papamokos E; Musil D
    Eur J Biochem; 1987 Aug; 166(3):673-92. PubMed ID: 3301348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Despite having a common P1 Leu, eglin C inhibits alpha-lytic proteinase a million-fold more strongly than does turkey ovomucoid third domain.
    Qasim MA; Van Etten RL; Yeh T; Saunders C; Ganz PJ; Qasim S; Wang L; Laskowski M
    Biochemistry; 2006 Sep; 45(38):11342-8. PubMed ID: 16981694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of an oligomer of proteolytic zymogens: detailed conformational analysis of the bovine ternary complex and implications for their activation.
    Gomis-Rüth FX; Gómez-Ortiz M; Vendrell J; Ventura S; Bode W; Huber R; Avilés FX
    J Mol Biol; 1997 Jun; 269(5):861-80. PubMed ID: 9223647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.